Mikkel Østergaard

Mikkel Østergaard

Klinisk Professor, Klinisk professor

Medlem af:

  • Intern medicin: reumatologi


Udgivelsesår:
Alle
1 - 10 ud af 17Pr. side: 10
Sortering: Udgivelsesår
  1. 2004
  2. Udgivet

    Contrast injection in magnetic resonance imaging does not improve the assessment of destructive joint changes in rheumatoid arthritis – this is not true for the inflammatory changes.

    Ejbjerg, B., Thomsen, H. S., Jacobsen, S. & Østergaard, Mikkel, 2004. 0 s.

    Publikation: Konferencebidrag › Poster › Forskning

  3. Udgivet

    Low field, low cost, dedicated MRI in RA does perform as well as standard high field MRI for destructive joint changes and synovitis.

    Ejbjerg, B. & Østergaard, Mikkel, 2004. 0 s.

    Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

  4. Udgivet

    The sensitivity to change for destructive joint damage by the Sharp/van der Heijde X-ray scores and 2 different MRI approaches.

    Ejbjerg, B., Videbaek, C., Jacobsen, S., Thomsen, H. S. & Østergaard, Mikkel, 2004. 0 s.

    Publikation: Konferencebidrag › Poster › Forskning

  5. Udgivet

    Magnetic resonance imaging of wrist and finger joints in healthy subjects occasionally shows changes resembling erosions and synovitis as seen in rheumatoid arthritis.

    Ejbjerg, B., Narvestad, E., Rostrup, Egill, Szkudlarek, M., Jacobsen, S., Thomsen, H. S. & Østergaard, Mikkel, 2004, I: Arthritis & Rheumatism. 50, 4, s. 1097-1106

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

  6. Udgivet

    Reliability of a novel magnetic resonance imaging tenosynovitis scoring system in patients with rheumatoid arthritis.

    Haavardsholm, E. A., Kvan, N. P., Østergaard, Mikkel, Ejbjerg, B., Uhlig, T. A., Lilleås, F. G. & Kvien, T. K., 2004. 0 s.

    Publikation: Konferencebidrag › Poster › Forskning

  7. Udgivet

    Serum VEGF is increased in patients with early rheumatoid arthritis.

    Hetland, M. L., Johansen, J. S., Østergaard, Mikkel, Nielsen, H. J., Stengaard-Pedersen, K., Junker, P., Lottenburger, T., Hansen, I., Andersen, L. S., Tarp, U., Skjødt, H., Pedersen, J. K., Jacobsen, S., Svendsen, A., Ellingsen, T., Pødenphant, J., Hansen, G., Lindegaard, H. & Hørslev-Petersen, K., 2004. 0 s.

    Publikation: Konferencebidrag › Poster › Forskning

  8. Udgivet

    Serum VEGF increases in RA patients prior to relapse after withdrawal of DMARD.

    Hetland, M., Hansen, M. S., Stoltenberg, M., Gøtzsche, P., Østergaard, Mikkel & Hetland, Merete Lund, 2004. 0 s.

    Publikation: Konferencebidrag › Poster › Forskning

  9. Udgivet

    Changes in prescription practice of biological drugs in rheumatoid arthritis during the first three years of post-marketing use in Denmark and Norway: Criteria are becoming less stringent.

    Hjardem, E., Hetland, M. L., Østergaard, Mikkel & Kvien, T. K., 2004. 0 s.

    Publikation: Konferencebidrag › Poster › Forskning

  10. Udgivet

    Do patients benefit from switching to a second biologic drug when the first is withdrawn due to lack of efficacy or adverse events?

    Hjardem, E., Østergaard, Mikkel & Hetland, M. L., 2004. 0 s.

    Publikation: Konferencebidrag › Poster › Forskning

  11. Udgivet

    Aggressive non-biologic therapy eliminates radiographic progression in early rheumatoid arthritis – results from a randomised controlled trial of methotrexate, intraarticular steroid and cyclosporine/placebo (CIMESTRA).

    Hørslev-Petersen, K., Østergaard, Mikkel, Carvalho, A., Stengaard-Pedersen, K., Junker, P., Lottenburger, T., Hansen, I., Andersen, L. S., Tarp, U., Skjødt, H., Pedersen, J. K., Majgaard, O., Svendsen, A., Ellingsen, T., Pødenphant, J., Hansen, G., Lindegaard, H. & Hetland, M. L., 2004. 0 s.

    Publikation: Konferencebidrag › Poster › Forskning

Forrige 1 2 Næste

ID: 6953